Items where authors include "Barnard, L"

Export as [feed] Atom [feed] RSS
Number of items: 7.

Article

Gunn, D, Topan, R, Barnard, L orcid.org/0000-0001-5436-6882 et al. (19 more authors) (2023) Randomised, placebo-controlled trial and meta-analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: The TRITON trial. Alimentary Pharmacology & Therapeutics, 57 (11). pp. 1258-1271. ISSN 0269-2813

Forster, A orcid.org/0000-0001-7466-4414, Ozer, S, Brindle, R et al. (15 more authors) (2023) An intervention to support stroke survivors and their carers in the longer term: results of a cluster randomised controlled feasibility trial (LoTS2Care). Pilot and Feasibility Studies, 9. 40. ISSN 2055-5784

Royle, K-L orcid.org/0000-0003-0225-1199, Coulson, AB, Ramasamy, K et al. (26 more authors) (2022) Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial. BMJ Open, 12 (11). e063037. ISSN 2044-6055

Forster, A orcid.org/0000-0001-7466-4414, Ozer, S, Crocker, TF orcid.org/0000-0001-7450-3143 et al. (34 more authors) (2021) Longer-term health and social care strategies for stroke survivors and their carers: the LoTS2Care research programme including cluster feasibility RCT. Programme Grants for Applied Research, 9 (3). pp. 1-268. ISSN 2050-4322

Forster, A orcid.org/0000-0001-7466-4414, Hartley, S, Barnard, L et al. (14 more authors) (2018) An intervention to support stroke survivors and their carers in the longer term (LoTS2Care): study protocol for a cluster randomised controlled feasibility trial. Trials, 19 (1). 317.

Matthes, K, Funke, B, Anderson, M et al. (25 more authors) (2017) Solar Forcing for CMIP6 (v3.2). Geoscientific Model Development, 10 (6). pp. 2247-2302. ISSN 1991-959X

Proceedings Paper

Yong, K, Royle, K-L orcid.org/0000-0003-0225-1199, Ramasamy, K et al. (23 more authors) (2022) Risk-Adapted Therapy Directed According to Response (RADAR, UK-MRA Myeloma XV) - Comparing MRD-Guided Treatment Escalation and De-Escalation Strategies in Patients with Newly Diagnosed Myeloma Suitable for Stem Cell Transplantation. In: Blood. 64th ASH Annual Meeting, 10-13 Dec 2022, New Orleans, Louisiana. American Society of Hematology , pp. 1844-1846.

This list was generated on Sat Apr 20 05:51:03 2024 BST.